Episode 20 - The Impact of GLP-1 Receptor Agonists with Dr Suman Srinivasa

Going anti-Viral

Episode 20 - The Impact of GLP-1 Receptor Agonists with Dr Suman Srinivasa

In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Suman Srinivasa from Harvard Medical School about the impact of GLP-1 receptor agonists on diabetes and obesity. They discuss the mechanisms, benefits, and current and potential applications, including their use by people with HIV. The episode also highlights future prospects and challenges, including access to medication.

00:00 Introduction

01:42 Understanding GLP-1 Receptor Agonists

03:19 Mechanisms and Benefits of GLP-1 Receptor Agonists

05:34 Clinical Applications and Insurance Challenges

09:56 GLP-1 Receptor Agonists in HIV Patients

15:50 Future Prospects and Broader Applications

23:37 Closing Remarks

__________________________________________________
Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.
Email [email protected] to send feedback, show suggestions, or questions to be answered on a later episode.
Follow Going anti-Viral on:
Apple Podcasts
YouTube
X
Facebook
Instagram
...